Litcius/Paper detail

Obesity Augments Glucocorticoid-Dependent Muscle Atrophy in Male C57BL/6J Mice

Laura C. Gunder, Innocence Harvey, JeAnna R. Redd, Carol Davis, Ayat AL-Tamimi, Susan V. Brooks, Dave Bridges

2020Biomedicines17 citationsDOIOpen Access PDF

Abstract

Glucocorticoids promote muscle atrophy by inducing a class of proteins called atrogenes, resulting in reductions in muscle size and strength. In this work, we evaluated whether a mouse model with pre-existing diet-induced obesity had altered glucocorticoid responsiveness. We observed that all animals treated with the synthetic glucocorticoid dexamethasone had reduced strength, but that obesity exacerbated this effect. These changes were concordant with more pronounced reductions in muscle size, particularly in Type II muscle fibers, and potentiated induction of atrogene expression in the obese mice relative to lean mice. Furthermore, we show that the reductions in lean mass do not fully account for the dexamethasone-induced insulin resistance observed in these mice. Together, these data suggest that obesity potentiates glucocorticoid-induced muscle atrophy.

Topics & Concepts

GlucocorticoidEndocrinologyInternal medicineMuscle atrophyDexamethasoneAtrophyObesitySkeletal muscleBiologyInsulin resistanceMedicineMuscle Physiology and DisordersExercise and Physiological ResponsesAdipose Tissue and Metabolism